glp-1 medical Medications: Everything You Need to Know 1 journey with Side Effect Relief GLP-1 is one of the

Clinical trials show weight loss averaging 15-17% of body weight over a year

Llewellyn DC, Logan Ellis H, Aylwin SJ, et al

A key double-blind, placebo-controlled phase II study conducted over 72 weeks recruited 320 individuals with histologically confirmed NASH and liver fibrosis classified as stage F1 to F3

This phase 3 multicenter study, which is coordinated by Cleveland Clinics C5Research academic research organization, is enrolling 15,000 adults with overweight or obesity (BMI 27) who do not have diabetes but do have either established CVD or multiple CVD risk factors

Back Eng, J, Kleinman, WA, Singh, L, et al (April 1992) 'Isolation and characterisation of Exendin-4, an Exendin-3 analogue, from heloderma suspectum venom', The Journal of Biological Chemistry , 267/11, 7402-06